Dr. Gbolahan Amusa covers biopharmaceutical companies. Dr. Amusa looks for companies that can create value for the overall global health care system either through disruptive innovation in developed markets and/or by providing access to medicines in less developed nations. He is focusing on emerging areas such as gene therapy treatments, stem cells and regenerative medicines, and personalized genomics health care. Dr. Amusa says innovation is higher than it has been historically, as drug approvals last year had their second best year in history.
Full interview available here.
Gbola Amusa of Chardan Identifies the M&A Targets in CRISPR Genetic Medicines
March 29, 2018
Gbola Amusa of Chardan Partners is a Genius
September 14, 2021
Gene Therapy Equity Analyst Dr. Gbola Amusa Details His Top Four in 2019
April 08, 2019
Chardan Analyst: Gene Therapy Stocks Start their Long Ride to the Upside
October 01, 2021
Interview Highlights: Joseph Walewicz of Laurentian Bank Securities on Biotechnology and Pharmaceuticals
August 22, 2016
